431 related articles for article (PubMed ID: 32651080)
21. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
Smith LA; McKay CJ
Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
[TBL] [Abstract][Full Text] [Related]
22. Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography.
Koshita S; Fujita N; Noda Y; Kobayashi G; Ito K; Horaguchi J; Kanno Y; Ogawa T; Masu K; Michikawa Y; Iwashita Y; Sawai T; Uzuki M; Fujishima F
J Hepatobiliary Pancreat Sci; 2015 Apr; 22(4):301-9. PubMed ID: 25488889
[TBL] [Abstract][Full Text] [Related]
23. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
24. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
[TBL] [Abstract][Full Text] [Related]
25. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
27. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
[TBL] [Abstract][Full Text] [Related]
28. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
29. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
30. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.
Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M
Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938
[TBL] [Abstract][Full Text] [Related]
31. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma.
Amini N; Rezaee N; Habib JR; Blair A; Beckman RM; Manos L; Cameron JL; Hruban RH; Weiss MJ; Fishman EK; Zaheer A; Lafaro KJ; Burkhart RA; O'Broin Lennon AM; Burns WR; He J; Wolfgang CL
HPB (Oxford); 2021 Mar; 23(3):468-474. PubMed ID: 32912834
[TBL] [Abstract][Full Text] [Related]
32. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
[TBL] [Abstract][Full Text] [Related]
33. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
[No Abstract] [Full Text] [Related]
34. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
[TBL] [Abstract][Full Text] [Related]
35. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI.
Choi SY; Kim JH; Yu MH; Eun HW; Lee HK; Han JK
Abdom Radiol (NY); 2017 May; 42(5):1449-1458. PubMed ID: 28144718
[TBL] [Abstract][Full Text] [Related]
37. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
[TBL] [Abstract][Full Text] [Related]
38. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
40. Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas.
Pagliari D; Saviano A; Serricchio ML; Dal Lago AA; Brizi MG; Lanza F; Manfredi R; Gasbarrini A; Attili F
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2858-2874. PubMed ID: 28682431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
